Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy

Eur Urol Focus. 2025 Nov;11(6):915-920. doi: 10.1016/j.euf.2025.07.010. Epub 2025 Jul 28.

Abstract

prePSMA is a randomized controlled trial in which patients with high-risk prostate cancer and selected cases with intermediate-risk disease are randomized to a control arm in which all patients undergo extended pelvic lymph node dissection (ePLND), or an experimental arm in which ePLND is only performed in patients with positive preoperative findings on prostate-specific membrane antigen positron emission tomography/computed tomography.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Equivalence Trials as Topic
  • Humans
  • Laparoscopy* / methods
  • Lymph Node Excision* / methods
  • Male
  • Multicenter Studies as Topic
  • Pelvis
  • Positron Emission Tomography Computed Tomography* / methods
  • Preoperative Care / methods
  • Prostatectomy* / methods
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / surgery
  • Robotic Surgical Procedures* / methods
  • Triage / methods